A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis

by | Jun 20, 2026 | Clinical Trials | 0 comments

​ Conditions: Non-cystic Fibrosis Bronchiectasis

Interventions: Drug: HSK31858, tablet

Sponsors: Haisco Pharmaceutical Group Co., Ltd.

Recruiting Conditions: Non-cystic Fibrosis Bronchiectasis
Interventions: Drug: HSK31858, tablet
Sponsors: Haisco Pharmaceutical Group Co., Ltd.
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *